commercial weight loss centers – Page 2

Medifast Reports First Quarter Results – Slide Continues

April 28, 2025 According to CEO Dan Chard: “This year, we are focused on revitalizing our coach and customer base by supporting them with enhanced tools, data, and new products. Our business focus remains on reestablishing sustainable long-term growth while improving profitability.” First quarter 2025 revenue decreased 33.8% to $115.7 million from $174.7 million for the […]

Medifast Reports First Quarter Results – Slide Continues Read More »

2022 Census Data Published: Commercial Weight Loss Industry Statistics

News / John LaRosa

April 24, 2025 The U.S. Census of Service Industries is performed every 5 years, with the last government survey performed in 2022. Commercial weight loss companies (“diet & reducing centers”) are classified under NAICS code 812191 (other personal services). Establishment and firms data for this industry have just been released (see census.gov). This information is

2022 Census Data Published: Commercial Weight Loss Industry Statistics Read More »

Robard Begins Selling Diet Foods Direct to Consumers

News / John LaRosa

April 2, 2025 Robard, the medical weight loss company, has begun selling its shakes, puddings, soups and beverages direct to the public via a new website. These products are part of its New Direction program. This is a departure from its long-standing policy where you had to sign up for the program to get access

Robard Begins Selling Diet Foods Direct to Consumers Read More »

A Recession Is NOT The Time To Cut Marketing

News / John LaRosa

March 31, 2025 Many economists and analysts are saying that a recession is coming sometime this year. That said, many weight loss companies and their top managers will say they’ll have to cut expenses, especially marketing. That’s the knee-jerk reaction, but it’s dead wrong. When consumers cut back on spending, they will revert to trusted

A Recession Is NOT The Time To Cut Marketing Read More »

FDA Says No More Compounded Weight Loss Drugs – Industry OFA Appeal Shot Down

News / John LaRosa

March 14, 2025 On Mar. 5, a judge denied a request from the Outsourcing Facilities Association (OFA), an industry group for compounding pharmacies, to block the FDA’s attempt to stop the production of compounded tirzepatide. Generally, making copies of brand-name drugs is not legal until their patents expire. But there are exceptions: Compounding pharmacies can

FDA Says No More Compounded Weight Loss Drugs – Industry OFA Appeal Shot Down Read More »

Weight Watchers Reports Q4 and 2024 Yearly Results

News / John LaRosa

Feb. 27, 2025 WW reported its Q4 and full year 2024 results today. The company’s Board of Directors named Interim President and CEO Tara Comonte, to a permanent role as President and CEO, effective February 26, 2025. “We are pleased with the momentum in our Clinical business in the Fourth Quarter, reflecting the increasing demand

Weight Watchers Reports Q4 and 2024 Yearly Results Read More »

Conflicts in Trump Administration For Support of GLP-1 Meds

Uncategorized / John LaRosa

Feb. 3, 2025 Support for the wildly popular weight loss meds in the new administration appears to be a question mark. Dr. Oz has publicly praised GLP-1s for their benefits, even pitching them on TV and social media channels, according to a Dec. 30 report from The Hill. On the other hand, Mr. Kennedy expressed

Conflicts in Trump Administration For Support of GLP-1 Meds Read More »

Zepbound Beats Wegovy for Weight Loss

News / John LaRosa

Dec. 4, 2024 StatNews.com today reported that…. Eli Lilly’s drug Zepbound resulted in weight loss that was 47% greater than the weight loss achieved with Wegovy, the rival medicine made by Novo Nordisk, according to a new head-to-head study out this morning. The news likely will not be entirely surprising to the physicians and scientists

Zepbound Beats Wegovy for Weight Loss Read More »

Herbalife Weight Management Sales Continue Slide

Uncategorized / John LaRosa

November 20, 2024 Herbalife’s sales of weight management products in North America continue to decline, most likely due to strong competition from the GLP-1 weight loss drugs. Total U.S. sales for the 9 months ended Sept. 30, 2024 were down 7.9%, and North American sales represented 21% of the total. Total weight management sales from

Herbalife Weight Management Sales Continue Slide Read More »

23 and me To Enter The Weight Loss Market

News / John LaRosa

August 13, 2024 As reported by Fiercehealthcare.com today in an article… The genetic testing company 23andMe sees an opportunity to get in on the weight loss boom. The company, through its Lemonaid Health business, plans to launch a GLP-1 weight loss telehealth membership by the end of the month, it announced last week along with

23 and me To Enter The Weight Loss Market Read More »